{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:09:11Z","timestamp":1789042151114,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010030","name":"China National Textile And Apparel Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.plefa.2026.102749","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:30:12Z","timestamp":1780417812000},"page":"102749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiovascular safety profile of prostaglandin E and prostacyclin analogues: Clinical reports and ex vivo studies on human coronary arteries"],"prefix":"10.1016","volume":"210","author":[{"given":"Gaelle","family":"Merheb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Abdelazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Senbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izza","family":"Moude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hichem","family":"Badji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylou","family":"Para","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Abifadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Longrois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-3359","authenticated-orcid":false,"given":"Xavier","family":"Norel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2026.102749_bib0001","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2026.102749_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41589-018-0160-y","article-title":"Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor","volume":"15","author":"Audet","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.plefa.2026.102749_bib0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12079-020-00585-0","article-title":"A review of prostanoid receptors: expression, characterization, regulation, and mechanism of action","volume":"15","author":"Biringer","year":"2021","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.plefa.2026.102749_bib0004","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1211\/0022357021778655","article-title":"Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques","volume":"54","author":"Sharif","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0005","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.bjp.0703525","article-title":"Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor","volume":"130","author":"Davis","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI109292","article-title":"Selective binding site for [3H]prostacyclin on platelets","volume":"63","author":"Siegl","year":"1979","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2026.102749_bib0007","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.bjp.0706726","article-title":"GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist","volume":"148","author":"Wilson","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0008","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","article-title":"The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs","volume":"1483","author":"Abramovitz","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2026.102749_bib0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcp.2012.03.012","article-title":"Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist","volume":"84","author":"Whittle","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/jpet.107.124248","article-title":"2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug","volume":"322","author":"Kuwano","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plefa.2026.102749_bib0011","doi-asserted-by":"crossref","first-page":"F984","DOI":"10.1152\/ajprenal.90373.2008","article-title":"Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system","volume":"295","author":"Su","year":"2008","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.plefa.2026.102749_bib0012","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/mol.56.3.545","article-title":"Importance of the extracellular domain for prostaglandin EP(2) receptor function","volume":"56","author":"Stillman","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0013","first-page":"1001","article-title":"[Selective agonists and antagonists for prostaglandin E2 receptor subtypes]","volume":"45","author":"Maruyama","year":"2000","journal-title":"Tanpakushitsu KakuSan Koso"},{"key":"10.1016\/j.plefa.2026.102749_bib0014","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/pr.120.019331","article-title":"International Union of Basic and Clinical Pharmacology. CIX. Differences and similarities between human and rodent prostaglandin E2 receptors (EP1-4) and prostacyclin receptor (IP): specific roles in pathophysiologic conditions","volume":"72","author":"Norel","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.plefa.2026.102749_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114858","article-title":"Prostaglandin E2 EP receptors in cardiovascular disease: an update","volume":"195","author":"Bryson","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0016","article-title":"Misoprostol-induced coronary vasospasm complicated by Takotsubo cardiomyopathy and cardiac arrest","volume":"8","author":"Kaur","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.plefa.2026.102749_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-023-04082-w","article-title":"Comparison of the effect of vaginal misoprostol and evening primrose oil capsule with misoprostol alone on the consequences of abortion in women with intrauterine fetal death: a randomized clinical trial","volume":"23","author":"Hashemi","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.plefa.2026.102749_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.plefa.2026.102749_bib0021","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/bmj.302.6773.416-a","article-title":"A prostaglandin analogue as a probable cause of myocardial infarction in a young woman","volume":"302","author":"Fliers","year":"1991","journal-title":"BMJ"},{"issue":"20071202","key":"10.1016\/j.plefa.2026.102749_bib0022","first-page":"S160","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.plefa.2026.102749_bib0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/13625187.2016.1168799","article-title":"A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes","volume":"21","author":"Frye","year":"2016","journal-title":"Eur. J. Contracept. Reprod. Health Care: Off. J. Eur. Soc. Contracept."},{"key":"10.1016\/j.plefa.2026.102749_bib0024","doi-asserted-by":"crossref","first-page":"o819","DOI":"10.1136\/bmj.o819","article-title":"Mifepristone at home","volume":"376","author":"Cameron","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.plefa.2026.102749_bib0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0043-1770931","article-title":"Misoprostol use in obstetrics","volume":"45","year":"2023","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.plefa.2026.102749_bib0026","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.plefa.2026.102749_bib0028","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2019.08.003","article-title":"Coronary artery vasospasm after misoprostol treatment for incomplete abortion: a case report","volume":"100","author":"Mu\u00f1oz-Franco","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.plefa.2026.102749_bib0029","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/s41598-025-86422-z","article-title":"A disproportionality analysis of FDA adverse event reporting system events for misoprostol","volume":"15","author":"Yang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.plefa.2026.102749_bib0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/01443615.2019.1702629","article-title":"Acute myocardial infarction following misoprostol treatment","volume":"41","author":"Levin","year":"2021","journal-title":"J. Obstet. Gynaecol. (Lahore)"},{"key":"10.1016\/j.plefa.2026.102749_bib0031","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1574886312666171122100929","article-title":"Misoprostol-induced acute coronary syndrome in a premenopausal woman: a case report with literature review","volume":"13","author":"Mazhar","year":"2018","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.plefa.2026.102749_bib0032","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mce.2011.08.020","article-title":"Early pregnancy induced expression of prostaglandin E2 receptors EP2 and EP4 in the ovine endometrium and regulated by interferon tau through multiple cell signaling pathways","volume":"348","author":"Lee","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.plefa.2026.102749_bib0033","article-title":"[Cardiac arrest induced by vasospastic angina pectoris after vaginally administered misoprostol]","volume":"179","author":"Matthesen","year":"2017","journal-title":"Ugeskr. Laeger."},{"key":"10.1016\/j.plefa.2026.102749_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1115358","article-title":"A case report and literature review of myocardial infarction with nonobstructive coronary arteries (MINOCA) possibly due to acute coronary vasospasm induced by misoprostol","volume":"10","author":"Hau","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.plefa.2026.102749_bib0035","first-page":"166","article-title":"Nitroglycerin administration during cardiac arrest caused by coronary vasospasm secondary to misoprostol","volume":"12","author":"Owusu","year":"2015","journal-title":"J. Cardiol. Cases"},{"key":"10.1016\/j.plefa.2026.102749_bib0036","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.hlc.2020.09.441","article-title":"434 A case report of misoprostol associated coronary vasospasm and cardiac arrest","volume":"29","author":"Sugito","year":"2020","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.plefa.2026.102749_bib0037","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/0310057X9802600312","article-title":"Cardiac arrest associated with sulprostone use during caesarean section","volume":"26","author":"Chen","year":"1998","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.plefa.2026.102749_bib0038","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/aas.12022","article-title":"Cardiac arrest during sulprostone administration\u2013a case report","volume":"57","author":"Lampati","year":"2013","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.plefa.2026.102749_bib0039","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1034\/j.1399-6576.2002.460920.x","article-title":"Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage","volume":"46","author":"Krumnikl","year":"2002","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.plefa.2026.102749_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.AOG.0000173970.67736.92","article-title":"Extracorporeal membrane oxygenation therapy for circulatory arrest due to postpartum hemorrhage","volume":"107","author":"Reyftmann","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.plefa.2026.102749_bib0041","first-page":"195","article-title":"[Circulatory arrest following sulprostone administration in postpartum hemorrhage]","volume":"142","author":"Beerendonk","year":"1998","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.plefa.2026.102749_bib0042","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jclinane.2012.11.011","article-title":"Sulprostone for postpartum hemorrhage in a parturient with a history of Tako-tsubo cardiomyopathy","volume":"25","author":"Guerci","year":"2013","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.plefa.2026.102749_bib0043","doi-asserted-by":"crossref","first-page":"212.e1","DOI":"10.1016\/j.fertnstert.2006.11.010","article-title":"Medical management of early pregnancy failure in a patient with coronary artery disease","volume":"88","author":"Hackney","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.plefa.2026.102749_bib0044","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.4103\/jfmpc.jfmpc_831_21","article-title":"Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions","volume":"10","author":"Shukla","year":"2021","journal-title":"J. Family. Med. Prim. Care"},{"key":"10.1016\/j.plefa.2026.102749_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2022.106700","article-title":"DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE 2","volume":"165","author":"Bouhadoun","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.plefa.2026.102749_bib0047","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1476-5381.2010.01039.x","article-title":"Interaction of prostanoid EP3 and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE2","volume":"162","author":"Jones","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0048","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1096\/fj.201801064RR","article-title":"TP and\/or EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F2\u03b1 in mice and\/or humans","volume":"33","author":"Liu","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.plefa.2026.102749_bib0049","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1476-5381.1991.tb12474.x","article-title":"Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations","volume":"104","author":"Norel","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bjp.0701367","article-title":"Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells","volume":"122","author":"Kiriyama","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0051","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000057318","article-title":"Prostanoid signal integration and cross talk","volume":"11","author":"Wise","year":"2002","journal-title":"NeuroSignals (Karger AG)"},{"key":"10.1016\/j.plefa.2026.102749_bib0052","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101077R","article-title":"Endothelium-dependent contraction: the non-classical action of endothelial prostacyclin, its underlying mechanisms, and implications","volume":"35","author":"Liu","year":"2021","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.plefa.2026.102749_bib0053","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.placenta.2020.12.012","article-title":"PGE2 vs PGF2\u03b1 in human parturition","volume":"104","author":"Li","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.plefa.2026.102749_bib0054","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0090-6980(00)00103-9","article-title":"Effects of gestational age and labor on the expression of prostanoid receptor genes in pregnant baboon cervix","volume":"63","author":"Smith","year":"2001","journal-title":"Prostaglandins. Other Lipid Mediat."},{"key":"10.1016\/j.plefa.2026.102749_bib0055","first-page":"89","article-title":"Prostaglandin receptors in lower segment myometrium during gestation and labor","volume":"93","author":"Brodt-Eppley","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.plefa.2026.102749_bib0056","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0952-3278(03)00113-3","article-title":"Expression of prostanoid receptors in human lower segment pregnant myometrium","volume":"69","author":"Leonhardt","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plefa.2026.102749_bib0057","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1095\/biolreprod59.4.878","article-title":"Changes in expression of contractile FP and relaxatory EP2 receptors in pregnant rat myometrium during late gestation, at labor, and postpartum","volume":"59","author":"Brodt-Eppley","year":"1998","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.plefa.2026.102749_bib0058","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1097\/HJH.0b013e32833e868f","article-title":"Involvement of prostaglandin F2\u03b1 in preeclamptic human umbilical vein vasospasm: a role of prostaglandin F and thromboxane A2 receptors","volume":"28","author":"Topal","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.plefa.2026.102749_bib0059","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/jcdd9070198","article-title":"Acute coronary syndrome in pregnancy and the post-partum period","volume":"9","author":"O\u2019Kelly","year":"2022","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.plefa.2026.102749_bib0060","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.plefa.2026.102749_bib0061","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bcp.2019.05.026","article-title":"Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension","volume":"166","author":"Shen","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102749_bib0062","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00172-2024","article-title":"Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results","volume":"63","author":"Nathan","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.plefa.2026.102749_bib0063","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.1985.142","article-title":"Myocardial ischemia induced by prostacyclin and iloprost","volume":"38","author":"Bugiardini","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.plefa.2026.102749_bib0064","first-page":"882","article-title":"Effect of intracoronary and intravenous iloprost on coronary blood flow velocity in patients with coronary heart disease]","volume":"85","author":"Buerke","year":"1996","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.plefa.2026.102749_bib0065","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1532\/HSF98.20091020","article-title":"Randomized comparison of vasodilator effects of iloprost versus diltiazem on flow and pathologic changes in radial arteries: mid-term angiographic control study of the comparison of vasodilators on radial artery vasospasm","volume":"12","author":"Ustunsoy","year":"2009","journal-title":"Heart. Surg. Forum."},{"key":"10.1016\/j.plefa.2026.102749_bib0066","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/hrt.60.5.373","article-title":"Coronary artery calibre after direct intra-arterial infusion of epoprostenol (prostacyclin)","volume":"60","author":"Wilson","year":"1988","journal-title":"Heart."},{"key":"10.1016\/j.plefa.2026.102749_bib0067","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1399-6576.2006.01139.x","article-title":"Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction","volume":"50","author":"Theodoraki","year":"2006","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.plefa.2026.102749_bib0068","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1532\/HSF98.20051161","article-title":"Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery","volume":"9","author":"Baysal","year":"2006","journal-title":"Heart. Surg. Forum."},{"key":"10.1016\/j.plefa.2026.102749_bib0069","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial","volume":"165","author":"SIMONNEAU","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.plefa.2026.102749_bib0070","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.chest.2024.11.027","article-title":"Treatment with oral or inhaled treprostinil in patients with pulmonary arterial hypertension and cardiovascular comorbidities","volume":"167","author":"White","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.plefa.2026.102749_bib0071","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plefa.2026.102749_bib0072","article-title":"Acute myocardial infarction following inhaled treprostinil initiation","volume":"54","author":"Alqam","year":"2025","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.plefa.2026.102749_bib0073","doi-asserted-by":"crossref","first-page":"53036","DOI":"10.1074\/jbc.M405002200","article-title":"Dimerization of the Human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation*","volume":"279","author":"Wilson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2026.102749_bib0074","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejogrb.2011.01.015","article-title":"Cardiotocographic abnormalities associated with misoprostol and dinoprostone cervical ripening and labor induction","volume":"156","author":"Pevzner","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.plefa.2026.102749_bib0075","first-page":"159","article-title":"Uses of misoprostol in obstetrics and gynecology","volume":"2","author":"Allen","year":"2009","journal-title":"Rev. Obstet. Gynecol."},{"key":"10.1016\/j.plefa.2026.102749_bib0076","first-page":"324","article-title":"[Severe cardiovascular complications relating to Gemeprost therapy]","volume":"122","author":"Lauer","year":"2000","journal-title":"Zentralbl. Gynakol."},{"key":"10.1016\/j.plefa.2026.102749_bib0077","first-page":"192","article-title":"[Acute myocardial infarct following sulprostone administration]","volume":"142","author":"Feenstra","year":"1998","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.plefa.2026.102749_bib0078","first-page":"303","article-title":"[Acute myocardial infarction following administration of a synthetic analog of prostaglandin E2 in a subject with an intramural course of the anterior intraventricular artery]","volume":"28","author":"Cocco","year":"1998","journal-title":"G. Ital. Cardiol."},{"key":"10.1016\/j.plefa.2026.102749_bib0079","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/0310057X9802600312","article-title":"Cardiac arrest associated with sulprostone use during caesarean section","volume":"26","author":"Chen","year":"1998","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.plefa.2026.102749_bib0080","first-page":"719","article-title":"[Prolonged angina after the administration of a synthetic PGE2 derivative]","volume":"23","author":"Bagni","year":"1993","journal-title":"G. Ital. Cardiol."},{"key":"10.1016\/j.plefa.2026.102749_bib0081","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: study in 16, 369 women","volume":"71","author":"Ulmann","year":"1992","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.plefa.2026.102749_bib0082","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0002-9378(91)90092-6","article-title":"Acute myocardial infarction associated with prostaglandin","volume":"165","author":"Meyer","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.plefa.2026.102749_bib0083","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(87)90293-3","article-title":"Lack of effect of a 24-hour infusion of iloprost in intermittent claudication","volume":"46","author":"Hay","year":"1987","journal-title":"Thromb. Res."},{"key":"10.1016\/j.plefa.2026.102749_bib0084","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1253\/circj.CJ-10-0195","article-title":"Prostacyclin in vascular diseases - recent insights and future perspectives -: \u2013 Recent insights and future perspectives \u2013","volume":"74","author":"Kawabe","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.plefa.2026.102749_bib0085","first-page":"29","article-title":"Use of prostacyclin and its analogues in the treatment of cardiovascular disease","volume":"1","author":"Fink","year":"1999","journal-title":"Heart. Dis."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232782600027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232782600027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:19:23Z","timestamp":1789039163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232782600027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":81,"alternative-id":["S095232782600027X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102749","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular safety profile of prostaglandin E and prostacyclin analogues: Clinical reports and ex vivo studies on human coronary arteries","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102749"}}